{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["27(1)"],"submitter":["Parissenti A"],"journal":["Breast cancer research : BCR"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12337404"],"repository":["biostudies-literature"],"pubmed_title":["High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy"],"pmcid":["PMC12337404"],"pubmed_authors":["Haugen M","Lingjaerde O","Parissenti A","Theriault G","St-Onge R","Engebraaten O","Dahle M","Gythfeldt H","Masilamani T","Pritzker L","D’costa L"],"additional_accession":[]},"is_claimable":false,"name":"High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2026-05-29T16:34:28.309Z","creation":"2026-04-08T05:24:57.761Z"},"accession":"S-EPMC12337404","cross_references":{}}